顯示第 1 至 16 項結果,共 18 項
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-10.0-BT)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-10.0)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-10.3-BT)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-10.3)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-23.0-BT)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-23.0)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-3.0-BT)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-3.0)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-3.3-BT)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-3.3)
-
Anti-CD4 [CE9.1 (Clenoliximab)] (Ab00450-1.1-BT)
-
Anti-CD4 [CE9.1 (Clenoliximab)] (Ab00450-1.1)
-
Anti-CD4 [CE9.1 (Clenoliximab)] (Ab00450-1.4-BT)
-
Anti-CD4 [CE9.1 (Clenoliximab)] (Ab00450-1.4)
-
Anti-CD4 [CE9.1 (Clenoliximab)] (Ab00450-13.0-BT)
-
Anti-CD4 [CE9.1 (Clenoliximab)] (Ab00450-13.0)
